Inventor · disambiguated record
M. Amin Khan
Also filed as: KHAN M A · KHAN M AMIN · KHAN M Z I
61 granted patents·29 pending applications·2,801 citations·filing 1994–2024
99Inventor score
Files withAPTINYX INC35ALKERMES INC16UNIV NORTHWESTERN8TENACIA BIOTECHNOLOGY HONG KONG CO LTD7NAUREX INC4
Top patents by PatentIndex Score
90 records- 0199US10150769B2Spiro-lactam NMDA modulators and methods of using sameAPTINYX INC·Filed 2018·Granted Dec 11, 2018·20 cites·3 claims
- 0299US5912015AModulated release from biocompatible polymersALKERMES INC·Filed 1998·Granted Jun 15, 1999·557 cites·8 claims
- 0398US10195179B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Feb 5, 2019·18 cites·10 claims
- 0498US9925169B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Mar 27, 2018·19 cites·6 claims
- 0598US9512134B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Dec 6, 2016·35 cites·34 claims
- 0698US5656297AModulated release from biocompatible polymersALKERMES INC·Filed 1994·Granted Aug 12, 1997·404 cites·23 claims
- 0798US5654010AComposition for sustained release of human growth hormoneALKERMES INC·Filed 1995·Granted Aug 5, 1997·353 cites·11 claims
- 0898US5413797AControlled release ACTH containing microspheresALKERMES INC·Filed 1994·Granted May 9, 1995·330 cites·12 claims
- 0997US11077094B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2019·Granted Aug 3, 2021·7 cites·2 claims
- 1097US10052308B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2016·Granted Aug 21, 2018·19 cites·9 claims
- 1197US9579304B2Spiro-lactam NMDA receptor modulators and uses thereofAptinyx Incorporated·Filed 2016·Granted Feb 28, 2017·26 cites·7 claims
- 1297US9504670B2Spiro-lactam NMDA receptor modulators and uses thereofAptinyx Incorporated·Filed 2015·Granted Nov 29, 2016·28 cites·8 claims
- 1397US6749866B2Modulated release from biocompatible polymersALKERMES INC·Filed 2002·Granted Jun 15, 2004·76 cites·17 claims
- 1497US5667808AComposition for sustained release of human growth hormoneALKERMES INC·Filed 1995·Granted Sep 16, 1997·194 cites·5 claims
- 1596US10918637B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Feb 16, 2021·10 cites·18 claims
- 1696US10441572B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2018·Granted Oct 15, 2019·11 cites·2 claims
- 1796US10441571B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2018·Granted Oct 15, 2019·12 cites·2 claims
- 1896US10196401B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Feb 5, 2019·18 cites·10 claims
- 1996US9932347B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 3, 2018·19 cites·6 claims
- 2096US9828384B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Nov 28, 2017·24 cites·63 claims
- 2196US9802946B2NMDA receptor modulators and uses thereofUNIV NORTHWESTERN·Filed 2014·Granted Oct 31, 2017·22 cites·13 claims
- 2296US8673843B2NMDA receptors modulators and uses thereofMOSKAL JOSEPH·Filed 2012·Granted Mar 18, 2014·32 cites·12 claims
- 2395US11028095B2Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Jun 8, 2021·10 cites·20 claims
- 2495US10961189B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Mar 30, 2021·10 cites·25 claims
- 2595US10906913B2NMDA receptor modulators and uses thereofUNIV NORTHWESTERN·Filed 2017·Granted Feb 2, 2021·10 cites·4 claims
- 2695US6500448B1Composition for sustained release of human growth hormoneALKERMES INC·Filed 2000·Granted Dec 31, 2002·51 cites·37 claims
- 2794US9758525B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Sep 12, 2017·23 cites·45 claims
- 2894US9738650B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2014·Granted Aug 22, 2017·22 cites·37 claims
- 2994US9512133B2NMDA receptor modulators and uses thereofUNIV NORTHWESTERN·Filed 2013·Granted Dec 6, 2016·27 cites·11 claims
- 3093US9708335B2Spiro-lactam NMDA receptor modulators and uses thereofNAUREX INC·Filed 2014·Granted Jul 18, 2017·22 cites·62 claims
- 3192US10273239B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 30, 2019·10 cites·20 claims
- 3292US10253032B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2017·Granted Apr 9, 2019·10 cites·20 claims
- 3392US6379701B1Controlled release of metal cation-stabilized interferonALKERMES INC·Filed 2000·Granted Apr 30, 2002·21 cites·10 claims
- 3491US6051259AComposition for sustained release of human growth hormoneALKERMES INC·Filed 1999·Granted Apr 18, 2000·76 cites·12 claims
- 3590US5711968AComposition and method for the controlled release of metal cation-stabilized interferonALKERMES INC·Filed 1994·Granted Jan 27, 1998·73 cites·29 claims
- 3690US2025186392A1Spiro-lactam nmda receptor modulators and uses thereofTENACIA BIOTECHNOLOGY HONG KONG CO LTD·Filed 2024·Application pending·0 cites
- 3789US5891478AComposition for sustained release of human growth hormoneALKERMES INC·Filed 1998·Granted Apr 6, 1999·63 cites·12 claims
- 3888US10316041B2Spiro-lactam NMDA receptor modulators and uses thereofAPYTINYX INC·Filed 2017·Granted Jun 11, 2019·10 cites·20 claims
- 3988US6368630B1Modulated release from biocompatible polymersALKERMES INC·Filed 1999·Granted Apr 9, 2002·61 cites·11 claims
- 4087US11376250B2Spiro-lactam NMDA receptor modulators and uses thereofAPTINYX INC·Filed 2020·Granted Jul 5, 2022·1 cites·20 claims
- 4187US2025002495A1Spiro-lactam nmda modulators and methods of using sameTENACIA BIOTECHNOLOGY HONG KONG CO LTD·Filed 2024·Application pending·0 cites
- 4282US12157736B2Spiro-lactam NMDA modulators and methods of using sameTENACIA BIOTECHNOLOGY HONG KONG CO LTD·Filed 2022·Granted Dec 3, 2024·0 cites·4 claims
- 4380US12084444B2Spiro-lactam NMDA modulators and methods of using sameTENACIA BIOTECHNOLOGY HONG KONG CO LTD·Filed 2022·Granted Sep 10, 2024·0 cites·9 claims
- 4480US6165508AControlled release of metal cation-stabilized interferonALKERMES INC·Filed 1997·Granted Dec 26, 2000·39 cites·31 claims
- 4579US12167998B2Spiro-lactam NMDA receptor modulators and uses thereofTENACIA BIOTECHNOLOGY HONG KONG CO LTD·Filed 2021·Granted Dec 17, 2024·0 cites·2 claims
- 4677US6835754B2Use of aryl nitrone compounds in methods for treating neuropathic painRENOVIS INC·Filed 2002·Granted Dec 28, 2004·6 cites·16 claims
- 4776US2023312591A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2022·Application pending·0 cites
- 4875US9169280B2Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereofPHENOMENOME DISCOVERIES INC·Filed 2012·Granted Oct 27, 2015·3 cites·39 claims
- 4975US2023131402A1Spiro-lactam nmda receptor modulators and uses thereofAPTINYX INC·Filed 2022·Application pending·0 cites
- 5073US11427585B2Spiro-lactam NMDA modulators and methods of using sameAPTINYX INC·Filed 2020·Granted Aug 30, 2022·0 cites·9 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →